Merocar 500 mg/vial (IV Injection or Infusion)
Medicine Details
Category | Details |
---|---|
Generic | Meropenem trihydrate |
Company | Globe pharmaceuticals ltd |
Also available as |
Indications
- Pneumonia and Nosocomial Pneumonia
- Urinary Tract Infections
- Intra-abdominal Infections
- Gynaecological Infections
- Skin and Skin Structure Infections
- Meningitis
- Septicaemia
- Pulmonary infections in cystic fibrosis
- Empiric treatment for presumed infections in patients with febrile neutropenia
Pharmacology
Carbapenem antibiotic for parenteral use, interferes with bacterial cell wall synthesis, penetrates bacterial cell walls, stable against serine beta-lactamases, affinity for Penicillin Binding Proteins, potent bactericidal activity against broad spectrum of bacteria
Dosage
- Adults:
- 500 mg to 1 gm by intravenous administration every 8 hours
- 1 g IV every 8 hours for nosocomial pneumonias, peritonitis, presumed infections in neutropenic patients and septicaemia
- Upto 2 gm every 8 hours for cystic fibrosis
- 2 gm IV every 8 hours for meningitis
- Children:
- 10 to 40 mg/kg intravenously every 8 hours depending on type and severity of infection
- 20 mg/kg every 8 hours for intra-abdominal infections
- 25-40 mg/kg every 8 hours for cystic fibrosis
- 40 mg/kg IV every 8 hours for meningitis
- 20 mg/kg every 8 hours for febrile neutropenia
Administration
Intravenous Infusion over approximately 15-30 minutes or as intravenous bolus (5 to 20 ml) over approximately 3-5 minutes
Interaction
Competes with Merocar for active tubular secretion, inhibits renal excretion, may reduce serum valproic acid levels
Contraindications
Hypersensitivity to the product
Side Effects
- Inflammation
- Thrombophlebitis
- Pain at the site of injection
- Skin reactions like rash, pruritus, urticaria
- Abdominal pain
- Nausea
- Vomiting
- Diarrhea
- Headache
Pregnancy & Lactation
Pregnancy Category B, caution during nursing
Precautions & Warnings
Discontinue if allergic reaction occurs, careful monitoring in patients with hepatic disease
Use in Special Populations
- Dosage reduction in patients with creatinine clearance less than 51 ml/min
- No dosage adjustments necessary with impairment of liver function
- No dosage adjustments necessary in elderly patients unless creatinine clearance is <51 ml/min
- Infants under 3 months' efficacy and tolerability not established
Overdose Effects
Symptomatic treatment
Therapeutic Class
Other beta-lactam Antibiotics
Reconstitution
Intravenous bolus Administration: Reconstitute with sterile water for injection, Intravenous infusion administration: Constituted with compatible infusion fluid and then further diluted, Potency maintained for up to 3 hours at up to 25°C or 13 hours at up to 5°C
Storage Conditions
Store in a cool, dry place (below 30°C), away from light & moisture
Related Brands
- Merobac 1 gm/vial (IV Injection or Infusion) - popular-pharmaceuticals-ltd
- Merobac 500 mg/vial (IV Injection or Infusion) - popular-pharmaceuticals-ltd
- I-Penam 1 gm/vial (IV Injection or Infusion) - incepta-pharmaceuticals-ltd
- I-Penam 500 mg/vial (IV Injection or Infusion) - incepta-pharmaceuticals-ltd
- Fulspec 1 gm/vial (IV Injection or Infusion) - acme-laboratories-ltd